| #449 |
Damien Gloux |
CNRS |
1 |
| #449 |
Stephane Guilbert |
— |
1 |
| #449 |
Jean-Michel Saffin |
CNRS |
1 |
| #449 |
Pierre Labauge |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
1 |
| #449 |
Jean-Emmanuel Decams |
— |
1 |
| #449 |
Joelle Arnaud-Taillades |
Sanofi-Aventis |
1 |
| #449 |
Sylvie Villard |
CNRS |
1 |
| #449 |
Christophe Broca |
— |
1 |
| #449 |
Marc Criton |
CNRS |
1 |
| #449 |
Roger Pierre Petit |
— |
1 |
| #449 |
Claude Giral |
— |
1 |
| #449 |
Laure Hannibal |
Institut De Recherche Pour Le Developpement |
1 |
| #449 |
Christoph SPUHLER |
CNRS |
1 |
| #449 |
Thibaud Didier |
Quantum Surgical |
1 |
| #449 |
Yannick Fuchey |
Schlumberger Technology |
1 |
| #449 |
Ronan Meneu |
Schlumberger Technology |
1 |
| #449 |
Elodie Daynac |
Schlumberger Technology |
1 |
| #449 |
Delphine Coutrot |
Schlumberger Technology |
1 |
| #449 |
Francesco DiRenzo |
Arkema France |
1 |
| #449 |
Estelle Pescher |
Quantum Surgical |
1 |
| #449 |
Philippe Genevaux |
Horiba Abx Sas |
1 |
| #449 |
Erwan Lavarec |
— |
1 |
| #449 |
Benjamin Caillard |
CNRS |
1 |
| #449 |
Helene C. Lecacheux |
Eastman Kodak |
1 |
| #449 |
Said Attack |
— |
1 |
| #449 |
Marcel De Leeuw |
— |
1 |
| #449 |
Didier Cassier |
Sanofi-Synthelabo |
1 |
| #449 |
Philippe Bastard |
Sanofi-Synthelabo |
1 |
| #449 |
Isabelle Daffix |
Fournier Industrie Et Sante |
1 |
| #449 |
Nicolas Mourier |
Zambon S.P.A. |
1 |
| #449 |
Xavier Boulenc |
Sanofi-Synthelabo |
1 |
| #449 |
Frédéric De Lamotte |
GE |
1 |
| #449 |
Celine Granolleras |
Gambro Lundia Ab |
1 |
| #449 |
Francois Fajulas |
— |
1 |
| #449 |
Jacques Lafont |
CEA |
1 |
| #449 |
Samantha Noel |
— |
1 |
| #449 |
Michel Rumeau |
— |
1 |
| #449 |
Chantal Bertez |
— |
1 |
| #449 |
Jean-Pierre Liautard |
CNRS |
1 |
| #449 |
Gerard Bauduin |
Cegedur Societe De Transformation De L'Aluminum Pechiney |
1 |
| #449 |
Jean-Paul Blancheton |
Institut Francais De Recherche Pour L'Exploitation De La Mer (Ifremer) |
1 |
| #449 |
Jean-Marie Navarro |
L'Air Liquide, Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges Claude |
1 |
| #449 |
Pierre Preynat |
Goro S.A. |
1 |
| #449 |
Elisabeth Battais |
Laboratoires Chauvin-Blache |
1 |
| #449 |
Abbas Mattrod-Bashi |
Elf France |
1 |
| #449 |
Youssef H. Daher |
— |
1 |
| #449 |
Robert Filhoi |
Sanofi |
1 |
| #449 |
Jacques Rivoire |
— |
1 |
| #449 |
Andre Crastes de Paulet |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
1 |
| #449 |
P. Le Hao Dong |
Laboratoires Chauvin-Blache |
1 |